Cargando…
HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
BACKGROUND: HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent. O...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560712/ https://www.ncbi.nlm.nih.gov/pubmed/28817706 http://dx.doi.org/10.1371/journal.pone.0183511 |
_version_ | 1783257710220804096 |
---|---|
author | Dysangco, Andrew Liu, Ziyue Stein, James H. Dubé, Michael P. Gupta, Samir K. |
author_facet | Dysangco, Andrew Liu, Ziyue Stein, James H. Dubé, Michael P. Gupta, Samir K. |
author_sort | Dysangco, Andrew |
collection | PubMed |
description | BACKGROUND: HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent. OBJECTIVES: Our objectives were to determine the relationships between HIV infection, virologic suppression with antiretroviral therapy (ART), in vivo measures of conduit artery and microvascular endothelial function, and circulating biomarkers of pathways associated with CVD. METHODS: We performed a cross-sectional analysis of three prospectively enrolled groups from a single center: 28 were HIV-infected and virologically-suppressed on a regimen of FTC/TDF/EFV (HIV+ART+), 44 were HIV-infected but not on ART (HIV+ART-), and 39 were HIV-uninfected healthy volunteers (HIV-) matched to the HIV+ART- group for age, sex, smoking status, and height. None had diabetes, uncontrolled hypertension, known CVD, or other pro-inflammatory condition. Flow mediated dilation (FMD), nitroglycerin-mediated dilation (NTGMD), reactive hyperemia velocity time integral (RHVTI), and FMD/RHVTI of the brachial artery were measured, as well as circulating biomarkers of systemic inflammation, metabolism, oxidative stress, and endothelial activation. RESULTS: No significant differences were found amongst the three groups in FMD (P = 0.46), NTGMD (P = 0.42), RHVTI (P = 0.17), and FMD/RHVTI (P = 0.22) in unadjusted comparisons. Adjusted ANOVA models which included brachial artery diameter, demographics, and conventional CVD risk factors did not appreciably change these findings. In pairwise comparisons, the HIV+ART- group had significantly higher soluble tumor necrosis factor receptor II, soluble CD163, β-2 microglobulin, interferon-γ- induced protein-10, tissue inhibitor of metalloproteinase-1, and vascular cell adhesion molecule-1 compared to the other two groups (all p<0.05). Correlates of endothelial function differed between study groups. CONCLUSION: Although untreated HIV infection was associated with elevated levels of several biomarkers of inflammation and endothelial activation, we were unable to demonstrate differences in measures of conduit artery and microvascular endothelial function in this study population. |
format | Online Article Text |
id | pubmed-5560712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55607122017-08-25 HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress Dysangco, Andrew Liu, Ziyue Stein, James H. Dubé, Michael P. Gupta, Samir K. PLoS One Research Article BACKGROUND: HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent. OBJECTIVES: Our objectives were to determine the relationships between HIV infection, virologic suppression with antiretroviral therapy (ART), in vivo measures of conduit artery and microvascular endothelial function, and circulating biomarkers of pathways associated with CVD. METHODS: We performed a cross-sectional analysis of three prospectively enrolled groups from a single center: 28 were HIV-infected and virologically-suppressed on a regimen of FTC/TDF/EFV (HIV+ART+), 44 were HIV-infected but not on ART (HIV+ART-), and 39 were HIV-uninfected healthy volunteers (HIV-) matched to the HIV+ART- group for age, sex, smoking status, and height. None had diabetes, uncontrolled hypertension, known CVD, or other pro-inflammatory condition. Flow mediated dilation (FMD), nitroglycerin-mediated dilation (NTGMD), reactive hyperemia velocity time integral (RHVTI), and FMD/RHVTI of the brachial artery were measured, as well as circulating biomarkers of systemic inflammation, metabolism, oxidative stress, and endothelial activation. RESULTS: No significant differences were found amongst the three groups in FMD (P = 0.46), NTGMD (P = 0.42), RHVTI (P = 0.17), and FMD/RHVTI (P = 0.22) in unadjusted comparisons. Adjusted ANOVA models which included brachial artery diameter, demographics, and conventional CVD risk factors did not appreciably change these findings. In pairwise comparisons, the HIV+ART- group had significantly higher soluble tumor necrosis factor receptor II, soluble CD163, β-2 microglobulin, interferon-γ- induced protein-10, tissue inhibitor of metalloproteinase-1, and vascular cell adhesion molecule-1 compared to the other two groups (all p<0.05). Correlates of endothelial function differed between study groups. CONCLUSION: Although untreated HIV infection was associated with elevated levels of several biomarkers of inflammation and endothelial activation, we were unable to demonstrate differences in measures of conduit artery and microvascular endothelial function in this study population. Public Library of Science 2017-08-17 /pmc/articles/PMC5560712/ /pubmed/28817706 http://dx.doi.org/10.1371/journal.pone.0183511 Text en © 2017 Dysangco et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Dysangco, Andrew Liu, Ziyue Stein, James H. Dubé, Michael P. Gupta, Samir K. HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
title | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
title_full | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
title_fullStr | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
title_full_unstemmed | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
title_short | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
title_sort | hiv infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560712/ https://www.ncbi.nlm.nih.gov/pubmed/28817706 http://dx.doi.org/10.1371/journal.pone.0183511 |
work_keys_str_mv | AT dysangcoandrew hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress AT liuziyue hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress AT steinjamesh hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress AT dubemichaelp hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress AT guptasamirk hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress |